References
- Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78. doi:10.1111/j.1398-9995.2004.00526.x. PMID:15080825.
- National Asthma E, Prevention P. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clinic Immunol. 2007;120:S94–138. doi:10.1016/j.jaci.2007.09.029.
- Lang A, Carlsen KH, Haaland G, Devulapalli CS, Munthe-Kaas M, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy. 2008;63(8):1054–60. doi:10.1111/j.1398-9995.2008.01672.x. PMID:18691307.
- Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229–35. doi:10.1016/j.jaci.2012.01.039. PMID:22326484.
- Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swinston J, et al. Economic burden of asthma: a systemic review. BMC Pulm Med. 2009;9:24. doi:10.1186/1471-2466-9-24. PMID:19454036.
- Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Clin Respir J. 2002;19(1):61–7. doi:10.1183/09031936.02.00232001.
- Barnett, SBL, Nurmagambetov TA. Costs of asthma in the United States 2002–2007. J Allergy Clin Immunol. 2011; q127(1):145–52. doi:10.1016/j.jaci.2010.10.020.
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Clin Respir J. 2014;43(2):343–73. doi:10.1183/09031936.00202013.
- Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med. 2012;367(10):904–12 doi:10.1056/NEJMoa1203229. PMID:22938716.
- Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics. 2000;106(1):E8. doi:10.1542/peds.106.1.e8. PMID:10878177.
- Ordoñez GA, Phelan PD, Olinsky A, Robertson CF. Preventable factors in hospital admissions for asthma. Arch Dis Child. 1998;78(2):143–7. doi:10.1136/adc.78.2.143. PMID:9579156.
- Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996;98(6 Pt 1):1051–7. doi:10.1016/S0091-6749(96)80190-4. PMID:8977504.
- Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55. doi:10.1001/jama.295.13.1549. PMID:16595758.
- Kim SH, Sutherland ER, Gelfand EW. Is there a link between obesity and asthma? Allergy Asthma Immunol Res. 2014;6(3):189–95. doi:10.4168/aair.2014.6.3.189. PMID:24843792.
- Lang J. Obesity, nutrition, and asthma in children. Pediatr Allergy Immunol Pulmonol. 2012;25(2):64–75. doi:10.1089/ped.2011.0137. PMID:22768385.
- Global initiative for Asthma. Global strategy for asthma management and prevention. 2017. Available from: www.ginaasthma.org.
- Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005–15. doi:10.1056/NEJMoa1009705. PMID:21410369.
- Bhutani M, Yang WH, Hébert J, de Takacsy F, Stril JL. The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study. PLoS One. 2017;12(8):e0183869. doi:10.1371/journal.pone.0183869. PMID:28859150.
- Pavord ID, Korn S, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicenter, double-blind, placebo controlled trial. Lancet. 2012;38(9842):651–59. doi:10.1016/S0140-6736(12)60988-X.
- O'Hagan A, Morton R, Eid N. Loss of asthma control in pediatric patients after discontinuation of long-acting beta-agonists. Pulm Med. 2012;2012:894063. PMID:22966431
- Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology. 2008;13(4):559–63. doi:10.1111/j.1440-1843.2008.01292.x. PMID:18422868.
- Hendeles L, Khan YR, Shuster JJ, Chesrown SE, Abu-Hasan M. Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroids. Ann Allergy Asthma Immunol. 2015;114(1):58–62.e2. doi:10.1016/j.anai.2014.10.012. PMID:25528738.
- Ahmadisafshar A, Tabbekhha S, Mousavinasab N, Khoshnevis P. Relation between asthma and body mass index in 6–15 years old children. Acta Medica Iranica. 2013;51(9):615–9. PMID:24338192.
- Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–6. doi:10.1016/j.jaci.2017.04.009. PMID:28456623.
- Lucas J, Moonie S, Olsen-Wilson K, Hogan MB. Asthma, allergy, and obesity: examining the relationship among Nevada children. J Asthma. 2017;54(6):594–9. doi:10.1080/02770903.2016.1244829. PMID:27739908.
- Finkelstein E, Graham W, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014;133(5):854–62. doi:10.1542/peds.2014-0063. PMID:24709935.